ALEXANDRIA, Va., June 1 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'ATTRUVIQ' in its latest official gazette. The trademark application with the serial number 99413629 was filed on Sep. 25, 2025.
Here are the other related details:
Goods and Services: 5 - Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): BridgeBio Pharma, Inc. 3160 Porter Dr., Suite 250 Palo Alto CA California 94304 3 CORPORATION
Disclaimer: Curated by HT Syndication....